Table II.
Parameter | CASSS 0 | CASSS 1–3 | P-value |
---|---|---|---|
N (%) | 112 (27%) | 298 (73%) | – |
Age [years]* | 65.2 ±10.2 | 65.6 ±10.9 | 0.77 |
Sex (F/M) | 61 (15%)/51 (12%) | 83 (20%)/215 (53%) | < 0.001 |
25(OH)D [ng/ml]** | 16.8 (4.8–42.6) | 14.3 (4.0–48.4) | < 0.05 |
Patients in groups according to the level of 25(OH)D: | |||
0 – < 10 | 18 (4%) | 68 (17%) | 0.06 |
≥ 10 – < 20 | 56 (14%) | 166 (41%) | |
≥ 20 – < 30 | 29 (7%) | 51 (12%) | |
≥ 30 | 9 (2%) | 13 (3%) | |
Smoking (No/Yes/Ex-smokers) | 79 (19%)/15 (4%)/18 (4%) | 149 (36%)/93 (23%)/56 (14%) | < 0.001 |
Hyperlipidaemia (No/Yes) | 46 (12%)/63 (16%) | 144 (36%)/144 (36%) | 0.17 |
CAD status (stable CAD/ACS) | 96 (23%)/16 (4%) | 177 (43%)/121 (30%) | < 0.001 |
Data presented as mean ± SD;
data presented as median and range; other data presented as number of subjects (% of whole group).